Archive for May, 2020

Five Reasons Why This Pharmaceutical Specialist Could Double Your Money in Just Two Years

0 | By Michael A. Robinson

In our twice-weekly chats, I often suggest investments that are part of large tech sectors.

For instance, the life sciences field defines huge. Just the prescription drug segment alone will be worth $1.2 trillion by 2024, according to data from Statista.

So, you might be wondering why I am focused on a medical area that will be worth just 0.1% of that figure over roughly the same time frame.

It’s a fair question. The answer is pretty basic. A high-octane leader
focused on specialty drugs can make a killing.

And the one I’m going to reveal to you today defines profit machine. It’s on pace to double per-share earnings in as little as a year.

With that in mind, let me show you five reasons why this wealth-building biotech firm should at the very least be on your radar screen….

This Stock Crushed the Broader Market – And Now It’s Helping Exhausted Healthcare Workers

0 | By Michael A. Robinson

I want to start today’s chat with a tech-investing challenge.

How many of you can claim you have a stock in your portfolio that is up nearly 230% in just 16 months?

As impressive as that return sounds, it actually understates the strength of the stock I have in mind. It’s a medical device leader that recently received approval for a Covid-19 test.

It’s up 120 in the past two months alone…

But this is no flash in the pan. Even before that breakthrough occurred, the stock was a bona fide market crusher

From roughly the beginning of 2019 through the correction that began on February 19, the stock was ahead of the S&P 500 by an amazing 278.5%.

The firm I have in mind is leading the medical device market as part of a trend toward remote patient monitory.

With the coronavirus still fresh on everyone’s minds, the investment thesis is only getting better.

So, today I’m going to reveal why the stock could double in as little as three years and show you how to get in on the action

This Firm’s “Tactical Radar Systems” Could Double Your Money in Just Two Years

0 | By Michael A. Robinson

Ever since the market sold off back on February 19, I have given you a steady stream of tech winners who should at least be on your watchlist.

Here’s the thing. Most of those companies have been larger firms with stocks that have relatively high sticker prices.

And for good reason. When you’re in a bear market, you can often find big discounts on household names like Apple Inc. (AAPL).

But I would be remiss if I didn’t at least let you know from time to time about low priced small caps targeting Trump’s more than $700 billion defense budget.

Remember, what we want are well-run firms in multibillion-dollar markets with a lot of upside.

That’s just the set up I see in play for a tiny defense electronics firm that supplies the U.S. military with robust radar systems.

Today, I’m going to show you why this $4.00 stock could double in as little as two years…

The Titans of Tech Will Ride Out the Pandemic

0 | By Strategic Tech Investor Staff

Apple Inc. (AAPL) and Microsoft Corp. (MSFT) were bracing themselves for trouble when they warned early on that the coronavirus crisis might impact their next financial reports. That might be true, but that’s also the reason that the giants of big tech are in a great position to hang on and make an outstanding comeback, even if their stock prices drop in the short term. They are prepared to handle the challenge, whether that’s Apple transferring its business to purely online services, or Amazon.Com Inc. (AMZN) hiring to keep up with the now-indispensable delivery business. Not only that, but the fundamental long-term growth potential of new technologies like artificial intelligence hasn’t gone anywhere. A great moment to buy might be coming up soon. Click here to watch.

This Chipmaker Has Beaten the Coronavirus – But It Still Has Huge Profit Potential Ahead

0 | By Michael A. Robinson

I want to return to a conversation we had almost a year ago to the day.

See, back on May 24, 2019, I warned you to stay clear of Wall Street’s hype machine regarding a major tech merger.

At the time, I suggested you stay clear of investing in Hewlett Packard Enterprise Co. (HPE) even though it was joining forces with a storied supercomputing firm, Cray Inc.

Don’t get me wrong. I thought the buyout made a lot of sense for HPE since Cray is a computing legend with a long history of historic breakthroughs.

But I didn’t see a lot of upside ahead for the stock even though Cray had just nailed a $500 million U.S. government contract.

So, I’m happy to report that the “hidden” play on the merger that I suggested instead has become one of the top performers in the Covid-19 panic.

Now that the company has completed its own $6.9 billion merger, the stock is set to double from here

This Stock Has a Money-Doubling Record – And It’s Cashing in On A $17 Billion Drive to The Moon

0 | By Michael A. Robinson

President Donald J. Trump doesn’t seem content with his vast real estate empire here on Earth.

It’s not that he’s bored with his hotels, casinos, and golf courses scattered around the U.S.

No, he wants the nation to become a formidable space power. And that’s why he has his eyes squarely on the moon.

Don’t scoff. It could be worth a fortune. I’m not suggesting he plans to put his name on any structure that might be built there in the coming years – nothing like Trump Moon.

But he definitely wants to break ground there as soon as possible. Let me explain.

Trump recently signed an executive order to allow the U.S. to mine water and other lunar natural resources.

NASA hasn’t set date for wining mining will begin. But the agency intends to have us there in fairly short order.

Let me show why a storied aerospace leader is set to rake in a small fortune as a result

Live Market Expertise You Won’t Find Anywhere Else

0 | By Michael A. Robinson

Technology paves the road to wealth, which is why I want to make sure you know how to make incredible profits through the tech sector:

The folks at Money Morning, where I serve as the Defense + Tech Specialist, recently shared some of my insights on how to do just that:

This Stock Can Grow Your Wealth – And Virtually Ignore the Coronavirus

0 | By Michael A. Robinson

I want to start today’s chat with a question that is on the minds of millions of investors.

It’s particularly pressing for anyone over 50 or for those planning their retirement portfolios.

See, financial planners will tell their clients they should have some money in fixed income securities – and the closer to retirement the more of it.

Which brings us back round to investing’s existential question: how do you earn any meaningful bond yields in a zero-interest market?

Fortunately, I have the answer. And as you might imagine, it comes from the wealth-creating tech sector.

The firm I have in mind has quietly become a major player in electronic bond trading. Don’t scoff. Volume for this firm rose nearly 51% in March to $916.6 billion.

Not only that, but did I mention the stock is trading well above its price the day the stock market tanked with the coronavirus correction?

Let me show why the stock is set to double from here and should at least be on your wealth-building watchlist

This One Investment Covers an Entire Necessary Sector – And It’s Fighting Against the Coronavirus

0 | By Michael A. Robinson

Amid Big Media’s saturation coverage of the coronavirus panic, an important new medical breakthrough received scant attention.

After all, TV, radio, websites, newspapers, magazines and social media were riveted with stories about the spread of the new pandemic.

But working quietly behind the scenes, a team from Stanford University reported a new breakthrough in anti-aging biotech.

Indeed, the team discovered a way to “reset” the age of human cells – all the way back to zero.

Make no mistake. This is a major step forward. At the very least it could help cut the impact of osteoporosis that afflicts older people and costs the U.S. more than $75 billion a year.

With that in mind, today I’m going to tell you why this new development is so important for medicine and show you a great biotech investment that should at least be on your bear market watchlist…